Homrich & Berg’s Axonics, Inc. Common Stock AXNX Stock Holding History

Homrich & Berg’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,559	Closed	-$269K	–	358
2019 Q2	$269K	Buy	+6,559	New	+$184K	0.01%	294

Other funds holding AXNX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Homrich & Berg's AXNX Position: Q3 2019 in Review

Homrich & Berg sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2019, closing a stake of 6,559 shares — an estimated $269K sold.

Homrich & Berg first reported a position in AXNX in Q2 2019 and held it in 1 quarter. The position peaked at $269K in Q2 2019. 81 funds tracked by Wall St. Rank hold AXNX as of Q3 2019.

Homrich & Berg reported no remaining Axonics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Homrich & Berg sold 6,559 Axonics, Inc. Common Stock shares in Q3 2019, an estimated $269K.
Homrich & Berg first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Homrich & Berg's Axonics, Inc. Common Stock position peaked at $269K in Q2 2019.
81 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2019.

Based on Homrich & Berg's 13F filing for Q3 2019, filed 5 Nov 2019.